Clinical Trial Update: Lenalidomide in Combination With CHOP in Patients With Untreated PTCL [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for lenalidomide plus CHOP in untreated peripheral T-cell lymphoma (PTCL) across early phases; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alk-negative Anaplastic Large Cell Lymphoma
• Angioimmunoblastic T-cell Lymphoma
• Enteropathy-associated T-cell Lymphoma
• Peripheral T-cell Lymphoma
• Ptcl Nos

Drugs mentioned

• CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: PTCL, NOS, AITL | Phase 1, Phase 2 | Status: UNKNOWN